Publicaciones volver
Photodynamic therapy may worsen the prognosis of highly myopic choroidal neovascularisation treated by intravitreal bevacizumab.
Tipo: | Artículo |
Autores: | Ruiz-Moreno JM, Montero JA, Gomez-Ulla F. |
Títuto Revista: | The British journal of ophthalmology. |
Referencia: | |
Centro: | 02 - UCLM |
Photodynamic therapy may worsen the prognosis of highly myopic choroidal neovascularisation treated by intravitreal bevacizumab.
- PMID: 19939802 [PubMed - indexed for MEDLINE]